Patent · US Expired

HIV antisense expression vectors

US5583035A · kind A · utility

3Cited by

0References

4Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Axel Kretschmer · Wuppertal, DE
Horst-Peter Antonicek · Bensberg, DE
Jorg Baumgarten · Wuppertal, DE
Antonius Loebberding · Wuppertal, DE
Burkhard Mielke · Leverkusen, DE
Wolfgang Springer · Wuppertal, DE
Udo Stropp · Haan, DE
Mark-Michael Struck · Bern, CH
Lothar Biesert · Frankfurt am Main, DE
Helga Rubsamen-Waigmann · Bad Soden, DE
Hary Suhartono · Frankfurt, DE
Thomas-Peter Hausner · Cologne, DE

Key dates

Filing date	Nov 14, 1994
Grant date	Dec 10, 1996
Priority date	—
Expiry date	Nov 14, 2014

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2799/021
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to the targeted blocking of the genetic information of the viral messenger ribonucleic acid (mRNA) for virus replication (e.g. of HIV) in transfected, haematopoietic cells with particularly suitable expression systems, which express a complementary "antisense RNA".

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.